MetaCap

Maze Therapeutics (MAZE) Stock Chart

NASDAQ: MAZEHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

31.37-1.06 (-3.27%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

MAZE technical summary

MAZE is trading 6.8% above its 50-day simple moving average of $29.39 and 1.1% above its 200-day average of $31.02. The 50-day average is below the 200-day average, a configuration technical analysts associate with a longer-term downtrend. The 14-day Relative Strength Index (RSI) is 47.5, within the neutral 30 to 70 band.

Over the past year, the stock ranged from $21.95 (Sep 21, 2026) to $53.65 (Mar 16, 2026); the current price sits 30% of the way from the low to the high. Annualized 30-day volatility is 58.6%. Based on the last session's high, low and close, the classic pivot point is $31.68, with first resistance at $32.49 and first support at $30.57.

These indicators describe past price behavior for Maze Therapeutics; they are not predictions.

Summary generated from market data by MetaCap's automated system. Methodology

Technical indicators

Beta
—
1Y high
53.65 (Mar 16)
1Y low
21.95 (Sep 21)
Last close
31.37

MAZE price performance

1 week

-8.62%

1 month

-3.71%

3 months

+6.59%

6 months

+21.68%

Year to date

-24.28%

1 year

-13.49%

MAZE price return, excluding dividends.

Moving averages

Simple and exponential moving averages
PeriodSimple (SMA)Exponential (EMA)
5-day32.35Price below32.38Price below
10-day33.93Price below32.92Price below
20-day33.00Price below32.53Price below
50-day29.39Price above30.66Price above
100-day28.84Price above29.91Price above
200-day31.02Price above32.36Price below

Moving averages are computed from daily closing prices over the past year. What is a moving average?

Pivot points

Classic pivot points
LevelPrice
Resistance 3 (R3)34.41
Resistance 2 (R2)33.60
Resistance 1 (R1)32.49
Pivot point31.68
Support 1 (S1)30.57
Support 2 (S2)29.76
Support 3 (S3)28.65

Classic floor-trader pivots from the last session's high, low and close. How pivot points work

Learn technical analysis